238 related articles for article (PubMed ID: 33482362)
1. In-vivo assessment of a tissue engineered vascular graft computationally optimized for target vessel compliance.
Furdella KJ; Higuchi S; Behrangzade A; Kim K; Wagner WR; Vande Geest JP
Acta Biomater; 2021 Mar; 123():298-311. PubMed ID: 33482362
[TBL] [Abstract][Full Text] [Related]
2. Acute Elution of TGFβ2 Affects the Smooth Muscle Cells in a Compliance-Matched Vascular Graft.
Furdella KJ; Higuchi S; Kim K; Doetschman T; Wagner WR; Vande Geest JP
Tissue Eng Part A; 2022 Jul; 28(13-14):640-650. PubMed ID: 35521649
[TBL] [Abstract][Full Text] [Related]
3. Bioresorbable silk grafts for small diameter vascular tissue engineering applications: In vitro and in vivo functional analysis.
Gupta P; Lorentz KL; Haskett DG; Cunnane EM; Ramaswamy AK; Weinbaum JS; Vorp DA; Mandal BB
Acta Biomater; 2020 Mar; 105():146-158. PubMed ID: 31958596
[TBL] [Abstract][Full Text] [Related]
4. Computationally Optimizing the Compliance of Multilayered Biomimetic Tissue Engineered Vascular Grafts.
Tamimi EA; Ardila DC; Ensley BD; Kellar RS; Vande Geest JP
J Biomech Eng; 2019 Jun; 141(6):0610031-06100314. PubMed ID: 30778568
[TBL] [Abstract][Full Text] [Related]
5. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821
[TBL] [Abstract][Full Text] [Related]
6. An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.
Prichard HL; Manson RJ; DiBernardo L; Niklason LE; Lawson JH; Dahl SL
J Cardiovasc Transl Res; 2011 Oct; 4(5):674-82. PubMed ID: 21748530
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineered small-diameter vascular grafts.
Schmedlen RH; Elbjeirami WM; Gobin AS; West JL
Clin Plast Surg; 2003 Oct; 30(4):507-17. PubMed ID: 14621299
[TBL] [Abstract][Full Text] [Related]
8. Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.
Best CA; Szafron JM; Rocco KA; Zbinden J; Dean EW; Maxfield MW; Kurobe H; Tara S; Bagi PS; Udelsman BV; Khosravi R; Yi T; Shinoka T; Humphrey JD; Breuer CK
Acta Biomater; 2019 Aug; 94():183-194. PubMed ID: 31200116
[TBL] [Abstract][Full Text] [Related]
9. Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans.
Fang S; Ellman DG; Andersen DC
Cells; 2021 Mar; 10(3):. PubMed ID: 33807009
[TBL] [Abstract][Full Text] [Related]
10. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression.
Fukunishi T; Ong CS; He YJ; Inoue T; Zhang H; Steppan J; Matsushita H; Johnson J; Santhanam L; Hibino N
Tissue Eng Part A; 2021 Nov; 27(21-22):1368-1375. PubMed ID: 33599167
[TBL] [Abstract][Full Text] [Related]
11. Effect of implantation site on outcome of tissue-engineered vascular grafts.
Sologashvili T; Saat SA; Tille JC; De Valence S; Mugnai D; Giliberto JP; Dillon J; Yakub A; Dimon Z; Gurny R; Walpoth BH; Moeller M
Eur J Pharm Biopharm; 2019 Jun; 139():272-278. PubMed ID: 31004790
[TBL] [Abstract][Full Text] [Related]
12. Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.
Mirhaidari GJM; Barker JC; Breuer CK; Reinhardt JW
Tissue Eng Part C Methods; 2023 Feb; 29(2):72-84. PubMed ID: 36719780
[TBL] [Abstract][Full Text] [Related]
13. Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases.
Cummings I; George S; Kelm J; Schmidt D; Emmert MY; Weber B; Zünd G; Hoerstrup SP
Eur J Cardiothorac Surg; 2012 Jan; 41(1):167-72. PubMed ID: 21530291
[TBL] [Abstract][Full Text] [Related]
14. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
[TBL] [Abstract][Full Text] [Related]
15. Coaxially-structured fibres with tailored material properties for vascular graft implant.
Johnson R; Ding Y; Nagiah N; Monnet E; Tan W
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():1-11. PubMed ID: 30678891
[TBL] [Abstract][Full Text] [Related]
16. Computationally Optimizing the Compliance of a Biopolymer Based Tissue Engineered Vascular Graft.
Harrison S; Tamimi E; Uhlorn J; Leach T; Vande Geest JP
J Biomech Eng; 2016 Jan; 138(1):0145051-5. PubMed ID: 26593773
[TBL] [Abstract][Full Text] [Related]
17.
Keshavarzian M; Meyer CA; Hayenga HN
Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930
[TBL] [Abstract][Full Text] [Related]
18. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery.
Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS
Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324
[TBL] [Abstract][Full Text] [Related]
19. In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model.
Yeung E; Inoue T; Matsushita H; Opfermann J; Mass P; Aslan S; Johnson J; Nelson K; Kim B; Olivieri L; Krieger A; Hibino N
J Thorac Cardiovasc Surg; 2020 May; 159(5):1971-1981.e1. PubMed ID: 31864694
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate alters natural progression of tissue-engineered vascular grafts.
Chang YC; Li J; Mirhaidari G; Zbinden J; Barker J; Blum K; Reinhardt J; Best C; Kelly J; Shoji T; Yi T; Breuer C
FASEB J; 2021 Oct; 35(10):e21849. PubMed ID: 34473380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
